Boston Scientific Financial Ratios
NYSE: BSXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Boston Scientific ratio analysis
Boston Scientific earned a net margin of 14.4% in FY 2025, up from 11.0% a year earlier. Gross margin was 69.0% compared with a median of 68.8% over the prior 9 years. Return on equity reached 11.9%, meaning Boston Scientific generated 0.12 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.47 versus 0.49 the year before, and the current ratio was 1.62. At the end of FY 2025, BSX traded at 48.8 times earnings; across the 9 fiscal years shown, its year-end P/E ranged from 13.5 to 309.9, with a median of 61.6. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Boston Scientific financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 48.82 | 72.55 | 54.03 | 102.82 | 61.57 | — | 13.51 | 28.75 | 309.88 | 86.52 |
| Price / sales | 6.98 | 7.97 | 5.90 | 5.22 | 5.08 | 5.14 | 5.83 | 4.81 | 3.75 | 3.24 |
| Price / book | 5.79 | 6.13 | 4.36 | 3.77 | 3.63 | 3.32 | 4.51 | 5.41 | 4.84 | 4.36 |
| Gross margin | 69.0% | 68.6% | 69.5% | 68.8% | 68.8% | 65.0% | 71.0% | 71.4% | 71.3% | 65.7% |
| Operating margin | 18.0% | 15.5% | 16.5% | 13.0% | 10.1% | -0.8% | 14.1% | 15.3% | 14.2% | 4.9% |
| Net margin | 14.4% | 11.0% | 11.2% | 5.5% | 8.8% | -0.8% | 43.8% | 17.0% | 1.1% | 3.8% |
| Free cash flow margin | 18.2% | 15.8% | 12.6% | 7.4% | 11.1% | 11.4% | 12.8% | -0.1% | 12.2% | 8.9% |
| Return on equity (ROE) | 11.9% | 8.5% | 8.3% | 4.0% | 6.3% | -0.5% | 33.9% | 19.1% | 1.5% | 5.2% |
| Return on assets (ROA) | 6.6% | 4.7% | 4.5% | 2.1% | 3.2% | -0.3% | 15.4% | 8.0% | 0.5% | 1.9% |
| Debt / equity | 0.47 | 0.49 | 0.47 | 0.51 | 0.55 | 0.60 | 0.72 | 0.81 | 0.80 | 0.81 |
| Current ratio | 1.62 | 1.08 | 1.32 | 1.51 | 1.48 | 1.82 | 0.97 | 0.76 | 0.68 | 0.90 |
| Revenue growth | 19.9% | 17.6% | 12.3% | 6.7% | 19.9% | -7.7% | 9.3% | 8.6% | -0.3% | 12.5% |
| EPS growth | 55.2% | 16.8% | 137.8% | -34.8% | — | -102.4% | 179.8% | 1,387.5% | -68.0% | — |